ETOMIDATE
- Product NDC
- 51662-1485
- 11-digit product format
- 516621485
- Labeler code
- 51662
- Product ID
- 51662-1485_2b39a9d5-ca76-b107-e063-6394a90ae8bb
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ETOMIDATE
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- HF Acquisition Co LLC, DBA HealthFirst
- Application
- ANDA202354
- Marketing category
- ANDA
- Marketing start
- 2020-01-11
- Substance
- ETOMIDATE
- Active strength
- 2 mg/mL
- Pharmacologic classes
- General Anesthesia [PE], General Anesthetic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- ETOMIDATE
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ETOMIDATE | 2 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | Z22628B598 |
| Rxcui | 1654006 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 51662-1485-1 | ETOMIDATE | 10 mL in 1 VIAL, SINGLE-DOSE | INJECTION | 10 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51662-1485 | ETOMIDATE INJECTION [HF ACQUISITION CO LLC, DBA HEALTHFIRST] | 3 | Current NDC, Legacy NDC, 1 package rows | 20250110_9bdee875-4b48-c592-e053-2995a90a6485.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51662-1485-1 | 51662148501 | 10 mL in 1 VIAL, SINGLE-DOSE (51662-1485-1) | 10 ml | 2020-01-11 | 0000-00-00 | No | No | Current |